Can Combined Assessment of Baroreflex Sensitivity and Iodine-123 Metaiodobenzylguanidine Imaging Be Used for Risk Stratification of Patients With Type 2 Diabetes Mellitus?
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.